Myasthenia Gravis

Posted on Feb 4, 2019 by DelveInsight

Myasthenia gravis (MG)

Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved in signaling at the neuromuscular junction (NMJ). These proteins include the nicotinic Acetyl Cholinesterase (AChR) or, less frequently, a muscle-specific tyrosine kinase (MuSK). 

To get a free sample report, click the link: https://www.delveinsight.com/report-store/myasthenia-gravis-market-insight-epidemiology-and-market-forecast

(Visited 39 times, 1 visits today)
Close